RxDoctor Payments Data

Jeffrey Feldman, MD

Otolaryngology · Westerly, RINPI 1538250337

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.9% of the total across 172 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 20.5% — the pattern of someone who eats at a lot of different presentations.

$4,291in general payments, 2019–2025

Across 172 payments — averaging $24.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$879
  • GSK$833
  • Optinose US, Inc.$640
  • Regeneron Healthcare Solutions, Inc.$632
  • Inspire Medical Systems, Inc.$247
  • Medtronic$199
  • plus $860 from 12 others

What the payments were for

  • Food & beverage$4,285100%
  • Gifts$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,291 in reported general payments places this provider in the 75th percentile of 23 otolaryngology providers in Rhode Island.

See all otolaryngology providers in Rhode Island

Medicare billing

Part B allowed, 2024
$192,650
Medicare patients
463
Services billed
1,845

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mometasone Furoate35$2,749
Fluticasone Propionate115$1,598
SynthroidLevothyroxine Sodium21$1,581
Ipratropium Bromide54$1,441
Levothyroxine Sodium90$682
Montelukast Sodium28$463
Fluocinolone Acetonide Oil11$417
Cephalexin41$400
Omeprazole12$136
Oxycodone Hcl29$132
Lorazepam12$10

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Westerly

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →